Radiopharmaceutical Market 2020 With Top Countries Data : Key Country Analysis, Revenue, Production, Growth Rate, Opportunities, Trend, Demand and Forecast to 2024
Global “Radiopharmaceutical Market" Provides analysis and information according to market segments such as geography, technology classification and applications. Radiopharmaceutical market report focuses on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this Radiopharmaceutical Market report.
Final Report will add the analysis of the impact of COVID-19 on this Radiopharmaceutical industry.
Short Description About Radiopharmaceutical Market :
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Get a Sample PDF of report - https://www.360researchreports.com/enquiry/request-sample/13841672
The research covers the current Radiopharmaceutical market size of the market and its growth rates based on 5-year records with company outline of Key players/manufacturers:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
Scope of the Radiopharmaceutical Market Report:
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%. The worldwide market for Radiopharmaceutical is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 8120 million US$ in 2024, from 4940 million US$ in 2019, according to a new Research study.
This report focuses on the Radiopharmaceutical in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Inquire more and share questions if any before the purchase on this report at - https://www.360researchreports.com/enquiry/pre-order-enquiry/13841672
Report further studies the market development status and future Radiopharmaceutical Market trend across the world. Also, it splits Radiopharmaceutical market Segmentation by Type and by Applications to fully and deeply research and reveal market profile and prospects.
Major Classifications are as follows:
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
Major Applications are as follows:
- Oncology
- Cardiology
- Other
The Radiopharmaceutical Market Report Provides Answers to the following Key Questions:
- What will be the Radiopharmaceutical market size and the growth rate in 2024?
- What are the main key factors driving the global Radiopharmaceutical market?
- What are the key market trends impacting the growth of the global Radiopharmaceutical market?
- Which Trending factors influencing the market shares of the top regions across the globe?
- Who are the key market players and what are their strategies in the global Radiopharmaceutical market?
- What are the market opportunities and threats faced by the vendors in the global Radiopharmaceutical market?
- What industrial trends, drivers and challenges are manipulating its growth?
- What are the key outcomes of the five forces analysis of the global Radiopharmaceutical market?
Purchase this report (Price 3480 USD for a single-user license) - https://www.360researchreports.com/purchase/13841672
About Us:
360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.
Contact Us:
Name: Mr. Ajay More
Email: sales@360researchreports.com
Organization: 360 Research Reports
Phone: +44 20 3239 8187/ +14242530807
For More Related Reports Click Here :